Fingerprint
Dive into the research topics of 'Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Australian Ovarian Cancer Study (AOCS)
Research output: Contribution to journal › Article › peer-review
203
Scopus
citations